JP2015044878A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015044878A5 JP2015044878A5 JP2014248831A JP2014248831A JP2015044878A5 JP 2015044878 A5 JP2015044878 A5 JP 2015044878A5 JP 2014248831 A JP2014248831 A JP 2014248831A JP 2014248831 A JP2014248831 A JP 2014248831A JP 2015044878 A5 JP2015044878 A5 JP 2015044878A5
- Authority
- JP
- Japan
- Prior art keywords
- myxoma virus
- cancer cells
- pharmaceutical composition
- composition
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80364006P | 2006-06-01 | 2006-06-01 | |
| US60/803,640 | 2006-06-01 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013040387A Division JP5665899B2 (ja) | 2006-06-01 | 2013-03-01 | 癌の処置のための粘液腫ウイルス変異体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016197808A Division JP2017008105A (ja) | 2006-06-01 | 2016-10-06 | 癌の処置のための粘液腫ウイルス変異体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015044878A JP2015044878A (ja) | 2015-03-12 |
| JP2015044878A5 true JP2015044878A5 (https=) | 2015-04-23 |
Family
ID=38802246
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009513472A Withdrawn JP2009538935A (ja) | 2006-06-01 | 2007-06-01 | 癌の処置のための粘液腫ウイルス変異体 |
| JP2013040387A Expired - Fee Related JP5665899B2 (ja) | 2006-06-01 | 2013-03-01 | 癌の処置のための粘液腫ウイルス変異体 |
| JP2014248831A Pending JP2015044878A (ja) | 2006-06-01 | 2014-12-09 | 癌の処置のための粘液腫ウイルス変異体 |
| JP2016197808A Pending JP2017008105A (ja) | 2006-06-01 | 2016-10-06 | 癌の処置のための粘液腫ウイルス変異体 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009513472A Withdrawn JP2009538935A (ja) | 2006-06-01 | 2007-06-01 | 癌の処置のための粘液腫ウイルス変異体 |
| JP2013040387A Expired - Fee Related JP5665899B2 (ja) | 2006-06-01 | 2013-03-01 | 癌の処置のための粘液腫ウイルス変異体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016197808A Pending JP2017008105A (ja) | 2006-06-01 | 2016-10-06 | 癌の処置のための粘液腫ウイルス変異体 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US8512713B2 (https=) |
| EP (3) | EP2457584B1 (https=) |
| JP (4) | JP2009538935A (https=) |
| KR (1) | KR20090014364A (https=) |
| CN (1) | CN101460194B (https=) |
| AU (1) | AU2007256754B2 (https=) |
| CA (2) | CA2652228C (https=) |
| IL (1) | IL195297A (https=) |
| MX (1) | MX2008015265A (https=) |
| NZ (1) | NZ572893A (https=) |
| WO (1) | WO2007143548A2 (https=) |
| ZA (1) | ZA200809769B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007143548A2 (en) | 2006-06-01 | 2007-12-13 | Robarts Research Institute | Myxoma virus mutants for cancer treatment |
| FR2946536B1 (fr) * | 2009-06-11 | 2011-07-29 | Agronomique Inst Nat Rech | Utilisation d'une souche attenuee de myxoma virus comme oncolytique |
| US12128099B2 (en) | 2018-05-25 | 2024-10-29 | Bioventures, Llc | Myxoma virus compositions and methods of use |
| CA3112788A1 (en) * | 2018-09-05 | 2020-03-12 | Arizona Board Of Regents On Behalf Of Arizona State University | Oncolytic virus platform to treat hematological cancer |
| US12428626B2 (en) | 2018-11-20 | 2025-09-30 | Bioventures, Llc | Cells for the production of viruses and methods of using the same |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101618049A (zh) | 1997-10-09 | 2010-01-06 | 威尔斯塔特生物公司 | 使用病毒来治疗赘生物 |
| ES2153284B1 (es) | 1998-06-10 | 2001-09-01 | Fundacion Para El Estudio Y De | Nuevo virus recombinante de mixoma atenuado y su uso en la preparacion de vacunas mixtas contra la mixomatosis y la enfermedad hemorragica de los conejos. |
| IL145899A0 (en) | 1999-04-15 | 2002-07-25 | Pro Virus Inc | Treatment of neoplasms with viruses |
| AU6175000A (en) | 1999-07-12 | 2001-01-30 | Viron Therapeutics, Inc. | Novel myxoma genes for immune modulation |
| WO2001087324A1 (en) | 2000-05-17 | 2001-11-22 | Viron Therapeutics, Inc. | Compositions and methods for promoting immunosuppression |
| BR0207761A (pt) * | 2001-03-08 | 2006-01-31 | Akzo Nobel Nv | Uso de um vìrus leporipox recombinante vivo, vacina, e, vìrus leporipox recombinante vivo |
| JP4800924B2 (ja) * | 2003-03-07 | 2011-10-26 | ロバーツ リサーチ インスティテュート | 癌および慢性ウイルス感染の治療処置のための粘液腫症ウイルスの使用 |
| US20070207149A1 (en) | 2004-04-27 | 2007-09-06 | Wellstat Biologics Corporation | Cancer treatment using viruses and camptothecins |
| US20090035276A1 (en) | 2005-03-07 | 2009-02-05 | Robarts Research Institute | Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| WO2007143545A2 (en) | 2006-06-01 | 2007-12-13 | Robarts Research Institute | Tnf signaling in myxoma virus treatments |
| WO2007143548A2 (en) | 2006-06-01 | 2007-12-13 | Robarts Research Institute | Myxoma virus mutants for cancer treatment |
| WO2007147118A1 (en) | 2006-06-16 | 2007-12-21 | Robarts Research Institute | Infection of cells with myxoma virus requires akt activation |
-
2007
- 2007-06-01 WO PCT/US2007/070219 patent/WO2007143548A2/en not_active Ceased
- 2007-06-01 EP EP11184754.7A patent/EP2457584B1/en not_active Not-in-force
- 2007-06-01 CN CN2007800202887A patent/CN101460194B/zh not_active Expired - Fee Related
- 2007-06-01 JP JP2009513472A patent/JP2009538935A/ja not_active Withdrawn
- 2007-06-01 CA CA2652228A patent/CA2652228C/en not_active Expired - Fee Related
- 2007-06-01 US US12/301,961 patent/US8512713B2/en not_active Expired - Fee Related
- 2007-06-01 KR KR1020087029274A patent/KR20090014364A/ko not_active Ceased
- 2007-06-01 EP EP17182211.7A patent/EP3254694A1/en not_active Withdrawn
- 2007-06-01 MX MX2008015265A patent/MX2008015265A/es active IP Right Grant
- 2007-06-01 CA CA2951453A patent/CA2951453A1/en not_active Abandoned
- 2007-06-01 NZ NZ572893A patent/NZ572893A/en not_active IP Right Cessation
- 2007-06-01 AU AU2007256754A patent/AU2007256754B2/en not_active Ceased
- 2007-06-01 EP EP07798014A patent/EP2021023A4/en not_active Withdrawn
-
2008
- 2008-11-13 IL IL195297A patent/IL195297A/en active IP Right Grant
- 2008-11-13 ZA ZA200809769A patent/ZA200809769B/xx unknown
-
2013
- 2013-03-01 JP JP2013040387A patent/JP5665899B2/ja not_active Expired - Fee Related
- 2013-08-19 US US13/969,853 patent/US20130336930A1/en not_active Abandoned
-
2014
- 2014-12-09 JP JP2014248831A patent/JP2015044878A/ja active Pending
-
2016
- 2016-01-21 US US15/002,971 patent/US9980994B2/en active Active
- 2016-10-06 JP JP2016197808A patent/JP2017008105A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024010140A (es) | Nuevos metodos. | |
| IL288104B1 (en) | Heterocyclic compounds, pharmaceutical preparations containing them and their use for the treatment of cancer | |
| MX2022006107A (es) | Metodos y composiciones para dosificacion en terapia celular adoptiva. | |
| JP2014141525A5 (https=) | ||
| EP3686200A3 (en) | Bicyclic heterocycle compounds and their uses in therapy | |
| NZ780244A (en) | Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus | |
| CL2014001792A1 (es) | Compuestos derivados de carbamato; composicion farmaceutica, y uso de los mismos en el tratamiento del dolor, cancer por tumor solido, obesidad, entre otras enfermedades. | |
| BR212016030926U2 (pt) | conjugados de alvo e partículas e formulações dos mesmos | |
| IN2015DN00376A (https=) | ||
| WO2015048689A8 (en) | Inhibitors of bruton's tyrosine kinase | |
| WO2016004305A3 (en) | Inhibitors of bruton's tyrosine kinase | |
| WO2015031771A3 (en) | Administration of kynurenine depleting enzymes for tumor therapy | |
| JP2016518337A5 (https=) | ||
| TN2017000554A1 (en) | Novel combination for use in the treatment of cancer | |
| CN111344398A (zh) | 分离的重组溶瘤腺病毒、药物组合物及其在治疗肿瘤和/或癌症的药物中的用途 | |
| JP2015044878A5 (https=) | ||
| PH12015502616A1 (en) | Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer | |
| WO2014164285A3 (en) | Use of levocetirizine and montelukast in the treatment of vasculitis | |
| EA201790563A8 (ru) | Применение реслизумаба для лечения эозинофильной астмы со степенью тяжести от умеренной до тяжелой | |
| IL245738A0 (en) | Oxindole derivatives, ways of their preparation and their therapeutic use in the treatment of ampk-related diseases | |
| WO2016191458A3 (en) | Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment | |
| SG11202103097QA (en) | Cancer therapy by combination use of oncolytic vaccinia virus and immune checkpoint inhibitor, and pharmaceutical composition and combination medicine for use in the cancer therapy | |
| WO2015173701A3 (en) | Pharmaceutical compositions comprising danirixin for treating infectious diseases | |
| WO2015054678A3 (en) | Human papilloma virus therapeutic vaccine | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine |